Skip to evidence
Tiny Red HandsSearch
Back

VA clinicians warned more than 1,000 veterans could lose access to research treatment

Reporting and findings

  1. reported

    Internal VA warnings obtained by ProPublica said cuts could deprive more than 1,000 veterans of access to treatment studies; the administration restored some work, but advanced head-and-neck cancer trials remained stalled.

  2. documented

    Elon Musk was the Trump-appointed senior adviser who led DOGE work.

  3. documented

    Russell Vought was the Trump-appointed OMB director and acting CFPB director.

Summary and current status

Clinical-trial interruptions affect patients with metastatic cancer, kidney disease, brain injury, and other conditions lacking standard options.

Some decisions were reversed, but several trials remained stalled

People and organizations

Relationships in this file

  1. Elon Muskcut contracts and staff needed for research treatmentU.S. Department of Veterans Affairs
  2. Donald J. TrumpTrump-appointed senior adviser who led DOGE workElon Musk
  3. Donald J. TrumpTrump-appointed OMB director and acting CFPB directorRussell Vought

Figures

  1. Veterans warned at risk of losing research treatmentmore than 1,000 people
    Calculation details
    Basis
    Observed
    Population
    Veterans in affected VA studies identified by internal warnings
    Period
    2025-01-20 to 2025-05-06
    Method
    Count in internal VA issue briefs obtained by ProPublica.
    Uncertainty
    Prospective exposure count; some trials and positions were later restored.